FilingSEC EDGAR6-K
RedHill Biopharma Granted 180-Day Extension to Regain Nasdaq Compliance
· SEC accepted
StageCompliance extension granted
Filing content
The company received a 180-day extension from Nasdaq to regain compliance with the minimum bid price requirement, with a new deadline of April 5, 2027.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…